These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4622205)

  • 21. Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody.
    Gazengel C; Prieur AM; Jacques C; Buriot D; Nedellec J; Josso F
    Am J Hematol; 1978; 5(4):355-63. PubMed ID: 313704
    [No Abstract]   [Full Text] [Related]  

  • 22. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
    WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
    [No Abstract]   [Full Text] [Related]  

  • 23. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver.
    Green AJ; Ratnoff OD
    J Lab Clin Med; 1974 Feb; 83(2):189-97. PubMed ID: 4204243
    [No Abstract]   [Full Text] [Related]  

  • 25. Two genetic variants of von Willebrand's disease.
    Holmberg L; Nilsson IM
    N Engl J Med; 1973 Mar; 288(12):595-8. PubMed ID: 4539979
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes.
    Piovella F; Ascari E; Sitar GM; Malamani GD; Cattaneo G; Magliulo E; Storti E
    Haemostasis; 1974; 3(5-6):288-95. PubMed ID: 4619608
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
    Hougie C; Sargeant RB; Brown JE; Baugh RF
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
    [No Abstract]   [Full Text] [Related]  

  • 28. Precipitating anti-VIII:C antibodies in two patients with haemophilia A.
    Lavergne JM; Meyer D; Girma JP; Larrieu MJ
    Br J Haematol; 1982 Jan; 50(1):135-46. PubMed ID: 6798988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Affinity of factor 8 clotting activity for antigen detectable immunologically.
    Kernoff PB
    Nat New Biol; 1973 Aug; 244(135):148-9. PubMed ID: 4541892
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia.
    Bennett B; Ratnoff OD; Levin J
    J Clin Invest; 1972 Oct; 51(10):2597-601. PubMed ID: 4115706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.
    Zimmerman TS; Ratnoff OD; Powell AE
    J Clin Invest; 1971 Jan; 50(1):244-54. PubMed ID: 5543879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum accelerator factors and antihemophilic factor (AHF) in early phases of clotting.
    GRAHAM JB; LANGDELL RD; MORRISON FC; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):45-8. PubMed ID: 13224672
    [No Abstract]   [Full Text] [Related]  

  • 33. The factor VIII complex: structure and function.
    Hoyer LW
    Blood; 1981 Jul; 58(1):1-13. PubMed ID: 6165414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STUDIES OF THE ANTIHEMOPHILIC FACTOR (AHF, FACTOR VIII) PRODUCED IN VON WILLEBRAND'S DISEASE.
    BARROW EM; ROBERTS HR; PONS K; GRAHAM JB
    Proc Soc Exp Biol Med; 1964 Mar; 115():760-3. PubMed ID: 14155821
    [No Abstract]   [Full Text] [Related]  

  • 35. [Factor VIII-related antigen (F VIII R : Ag). Purification by immuno-affinity chromatography].
    Mazurier C; Parquet-Gernez A; Samor B; Goudemand M; Montreuil J
    C R Seances Acad Sci D; 1979 May; 288(18):1431-4. PubMed ID: 115608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Current knowledge of the AHF-like antigen.
    Meyer D
    Thromb Diath Haemorrh; 1975 Nov; 34(2):604-5. PubMed ID: 1081751
    [No Abstract]   [Full Text] [Related]  

  • 37. Determination of factor VIII-related antigen using commercial antisera.
    Chediak J; Maxey B; Telfer M
    Am J Clin Pathol; 1977 May; 67(5):462-9. PubMed ID: 404869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of von Willebrand's disease by means of the quantitative immunological assay of factor VIII-related antigen (author's transl)].
    Gruson R; Kernoff PB
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1593-5. PubMed ID: 4210557
    [No Abstract]   [Full Text] [Related]  

  • 39. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of five different rabbit antisera to factor VIII and the demonstration of a factor VIII related antigen in normal and von Willebrand's disease platelets.
    Shearn SA; Giddings JC; Peake IR; Bloom AL
    Thromb Res; 1974 Nov; 5(5):585-99. PubMed ID: 4614489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.